It was not significantly elevated in CMT1B, CMT1X (demyelinating CMTA forms) or CMT2A, CMT2E (axonal CMT forms), indicating it may be a biomarker specific to CMT1A, and not involved in the pathogenesis of other forms of CMT. This evidence concerns the gene PMP22 and Charcot-Marie-Tooth disease.